Retatrutide 20mg
Retatrutide 20mg represents a cutting-edge compound for advanced research into metabolic disorders and weight management. As a novel triple agonist targeting GLP-1, GIP, and glucagon receptors, Retatrutide offers a multifaceted approach to studying appetite regulation, glucose homeostasis, and energy expenditure. Early research indicates its significant potential in promoting weight loss and improving various metabolic parameters. This highly potent compound is provided in a 20mg formulation for detailed scientific investigation.
•Key Research Areas: Weight management, obesity, type 2 diabetes, metabolic syndrome, appetite regulation, glucose homeostasis.
•Formulation: 20mg Retatrutide.
•Mechanism: Triple agonist (GLP-1, GIP, Glucagon receptors).
Reviews
There are no reviews yet.